Medicine
|
Oncology |
|
|
|
Home > Disciplines > Medicine > Oncology > Prostate cancer > Prognosis > Prediction of castration resistance |
|
|
|
|
PREDICTION OF TIME TO HORMONAL TREATMENT FAILURE |
|
. |
Jadvar H, Velez E, Desai B, Ji L, Colletti PM, Quinn DI.
|
|
|
RISK OF CASTRATION RESISTANCE |
|
. |
Obata H, Shiota M, Akitake N, Takeuchi A, Kashiwagi E, Dejima T,
Kiyoshima K, Inokuchi J, Tatsugami K, Eto M. |
|
|
RISK FACTORS FOR PROGRESSION TO CASTRATION-RESISTANT PROSTATE CANCER |
|
|
Lin TT, Chen YH, Wu YP, Chen SZ, Li XD, Lin YZ, Chen SH, Zheng QS,
Wei Y, Xu N, Xue XY. |
|
|
PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME |
|
|
|
Observation after BCR without salvage therapy or delayed administration is a viable option for low-risk patients with a Gleason score ≤ 7 and PSADT ≥ 6 months, |
|
*** |
Matsumoto K, Niwa N, Hagiwara M, Kosaka T, Tanaka N, Takeda T,
Morita S, Mizuno R, Shinojima T, Hara S, Asanuma H, Oya M. |
|
|
|
|
|
|